Bohring–Opitz syndrome (BOS) with a new ASXL1 pathogenic variant

A new article on Bohring-Opitz Syndrome: Bohring–Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.

The auteurs, Silvana Beatriz Dangiolo, Ashley Wilson, Vaidehi Jobanputra and Kwame Anyane-Yeboa emphasize the importance of further phenotypic delineation of Bohring-Opitz Syndrome. In this case report whole exome sequencing analysis detected one novel disruptive frameshift mutation in the ASXL1 gene and the presence of two CFTR mutations which are associated with the patient’s chronic pancreatitis.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s